Merck sues US, calling move to cut drug prices "extortion"
Merck argues that a US law meant to cut costs for the elderly and disabled violates the constitution in suit filed Tuesday.
By Nacha Cattan, bloomberg
Merck & Co. is suing the US over a law that will allow the government to negotiate prescription-drug prices with pharmaceutical companies – a reform aimed at cutting costs for elderly and disabled Medicare patients that the health-care giant says is “tantamount to extortion.”
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
AstraZeneca exits PhRMA
For subscribers
